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ABSTRACT: Maximal expiratory flow in chronic obstructive pulmonary disease
(COPD) could be reduced by three different mechanisms; loss of lung elastic recoil,
decreased airway conductance upstream of flow-limiting segments; and increased
collapsibility of airways.
We hypothesized that decreased upstream conductance would be related to in-
flammation and thickening of the airway walls, increased collapsibility would be
related to decreased airway cartilage volume, and decreased collapsibility to inflam-
mation and thickening of the airway walls.
Lung tissue was obtained from 72 patients with different degrees of COPD, who
were operated upon for a solitary peripheral lung lesion. Maximal flow-static recoil
(MFSR) plots to estimate upstream resistance and airway collapsibility were derived
in 59 patients from preoperatively measured maximal expiratory flow-volume and
pressure-volume curves. In 341 transversely cut airway sections, airway size, air-
way wall dimensions and inflammatory changes were measured.
Airflow obstruction correlated with lung elastic recoil and the MFSR estimate of
airway conductance but not to airway collapsibility or to the amount of airway car-
tilage. The upstream conductance decreased as the inner wall became thicker. Airway
collapsibility did not correlate with the amount of airway cartilage, inflammation,
or airway wall thickness. We conclude that the maximal flow-static recoil model
does not adequately reflect the collapsibility of the flow-limiting segment.
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Reduced maximal expiratory flow is the physiologi-
cal abnormality which defines chronic obstructive pul-
monary disease (COPD) and is used as a measure of its
severity. Nevertheless, the exact mechanisms which are
responsible for the airflow obstruction in COPD remain
incompletely understood. Maximal expiratory flow in
COPD could be reduced by three different mechanisms.
Firstly, loss of lung elastic recoil can decrease the dri-
ving pressure [1, 2]. Secondly, inflammatory thicken-
ing and narrowing of airways can decrease the airway
conductance upstream of flow-limiting segments. Thirdly,
the collapsibility of airways and, therefore, of flow-limit-
ing segments can be increased due to processes such as
inflammatory destruction of bronchial cartilage. Decreased
cartilage volume in COPD has been described by seve-
ral authors [3–6], but was not found by others [7, 8].
It has been suggested that the relative contributions of
decreased lung recoil, decreased airway conductance and
increased airway collapsibility to flow obstruction dur-
ing forced expiration can be estimated from a maximal
flow-static recoil (MFSR) curve [9]. MFSR curves can
be constructed by plotting maximal flow at specific
lung volumes versus the corresponding transpulmonary
pressures. These measures are derived from maximal
expiratory flow-volume and pressure-volume curves. The
slope of the MFSR plot is a measure of airway conduc-
tance upstream from the flow-limiting segments. The
pressure-axis intercept of the MFSR curve is an index
of the collapsibility of the flow-limiting segments.
We hypothesized that decreased upstream conductance
would be related to inflammation and thickening of the
airway walls, increased collapsibility would be related
to decreased airway cartilage volume, and decreased col-
lapsibility to inflammation and thickening of the airway
walls.
These questions were addressed by measuring maxi-
mal expiratory flow-volume and pressure-volume curves
and constructing MFSR plots for 72 patients who had
varying degrees of airflow obstruction. Lung function
measurements were made in the week before resection
of a lung or lobe for a peripheral pulmonary lesion. With
these in vivo parameters of lung elastic recoil, MFSR
estimates of airway conductance and collapsibility to-
gether with morphometric measurements of the airway
structure, an attempt was made to separate the relative
importance of decreased recoil, decreased upstream con-
ductance and increased collapsibility of the flow-limit-
ing segments to airflow obstruction in COPD.
Methods
Study population
Lung tissue was obtained from 72 patients who had a
lobar resection or pneumonectomy for a solitary peri-
pheral lung lesion, and who showed no evidence at
pathological examination of obstructive pneumonitis.
Furthermore, patients who had a history consistent with
a diagnosis of asthma were excluded [10]. Informed con-
sent was obtained in all cases. Of the 72 patients, 64
proved to have bronchogenic carcinoma; carcinoid tumour,
hamartoma or granuloma was the final diagnosis in the
remaining patients. The clinical data for patients in this
study are summarized in table 1.
Pulmonary function studies
Pulmonary function tests were performed in the week
before surgery using a volume displacement pressure
compensated body plethysmograph. Thoracic gas vol-
ume was measured with a Krogh spirometer coupled to
a linear displacement transducer (Shaevitz Engineering,
Pennsauken, NJ, USA). Flow was measured with a Fleisch
No. 3 pneumotachometer coupled to a Sanborn 270 dif-
ferential pressure transducer (Sanborn Co., Waltham,
MA, USA). Functional residual capacity (FRC) was det-
ermined using the Boyle's law technique, and residual
volume (RV) and total lung capacity (TLC) were calcu-
lated after the determination of the expiratory reserve
volume and inspiratory capacity (IC). Forced expiratory
volume in one second (FEV1) and forced vital capacity
(FVC) were calculated from digitized flow and volume
signals obtained during forced expiratory manoeuvres.
At least three expiratory efforts were performed and the
forced expiratory manoeuvre with the largest sum of FEV1
and FVC was selected. As an indicator of the severity
of flow obstruction, the FEV1 and FEV1/FVC were used.
Values were expressed as percentage of the predicted
values (% pred) according to the summary equations of
the European Coal and Steel Community [11]. 
Static pressure-volume curves were obtained as descri-
bed previously [12]. Briefly, transpulmonary pressure
(PL) was measured using a differential pressure trans-
ducer (Validyne 45MP ±100 cmH2O; Validyne Co.,
Northridge, CA, USA), which compared airway opening
pressure to oesophageal pressure measured with a bal-
loon catheter. The volume signal was obtained from the
body plethysmograph. After three vital capacity breaths,
the subjects inhaled to TLC and the maximal static recoil
pressure (PL,max) was recorded with the glottis opened.
Multiple static pressure-volume points were obtained by
occluding the airway every 1–2 s during slow expiration
to FRC. At least three curves were obtained and a total
of not less than 18 pressure-volume points. The pres-
sure-volume data were analysed as described previous-
ly [13, 14]. All pressure-volume points between TLC and
FRC were used to derive an exponential relationship of
the form: V=A-Be-kP, where: V=lung volume; A=the lung
volume at infinite PL; B=the lung volume difference
between A and the lung volume at a PL of 0; k=the expo-
nential constant that describes the shape of the pres-
sure-volume curve; and P=transpulmonary pressure. The
recoil pressures at 90 and 60% TLC (PL,90 and PL,60)
were calculated, using the V=A-Be-kP equation [13, 14].
Construction of maximal flow-static recoil curves
A MFSR curve was obtained for each patient by plot-
ting maximal expiratory flow against the static transpul-
monary pressures at the same lung volumes (fig. 1). The
slope of the relatively linear part of the MFSR plot
between 70 and 30% vital capacity (VC) was calculated
to estimate upstream airway conductance during forced
expiration (Gus: L·s-1·cmH2O-1). For comparison with pre-
vious reports on MFSR analysis, Gus was also divided
by TLC (sGus: cmH2O·s-1). The pressure-axis intercept
of the extrapolated slope was used to estimate the criti-
cal transmural pressure causing airway collapse at the
flow limiting segment (Ptm': cmH2O) at which flow-
limiting airways narrow sufficiently to restrict airflow
according to the model described by PRIDE et al. [15].
Predicted Gus and Ptm' (Gus(pred) and Ptm'(pred)) were
predicted for individual patients as follows (fig. 1). Firstly,
TLC and FVC(pred) were calculated using the equations
of QUANJER et al. [11]. Secondly, the absolute lung vol-
umes at 75, 50 and 25% FVC (pred) were calculated by
subtracting, respectively, 25, 50 or 75% of FVC(pred)
from TLC(pred). Thirdly, the predicted recoil pressures
for these three lung volumes were calculated as follows:
the V=A-Be-kP equation was rearranged to P=((ln A-V)-
ln B)/k, where V is the lung volume at 75, 50 and 25%
FVC(pred) and A is the theoretical lung volume at infi-
nite transpulmonary pressure (we used TLC(pred) for A).
K and B were derived from the prediction equations of
COLEBATCH et al. [14] for k and B/A%. Fourthly, the
maximal expiratory flows at 75, 50 and 25% FVC(pred)
were derived from the equations of QUANJER et al. [11].
The three predicted flow recoil-pressure points at 75, 50
and 25% FVC(pred) were plotted on a flow-pressure dia-
gram and a regression line was plotted through the three
flow-pressure points for the 75–25% VC volume inter-
vals. The slope of the regression equation represents
Gus(pred) and the intercept on the pressure-axis repre-
sents Ptm'(pred). For statistical analysis, Gus was expres-
sed as a percentage of Gus(pred) (Gus%) and Ptm' as the
absolute difference of Ptm'(pred) - Ptm' (∆Ptm') (fig. 1).
With increased collapsibility of the flow-limiting seg-
ment, Ptm' will be more positive and, therefore, ∆Ptm'
more negative.
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Table 1.  –  Study population characteristics (n=72)
Age  yrs 61±9.5
(37–83)
Sex  M/F 54/18
Pack-yrs† 54.7±34.5 
(0.4–180)
Current smokers  n 45
Lifelong nonsmokers  n 2
Lung or lobe resected, right side  n 50
Lung or lobe resected, left side  n 22
†: pack-yrs=numbers of years smoking one pack of cigarettes
a day. Age and pack years are expressed as mean±SD and range
in parenthesis. M: male; F: female.
Morphological studies
Surgically resected specimens were inflated with either
10% formalin or 2.5% glutaraldehyde, at a pressure of
25 cmH2O, and submerged in fixative for at least 24 h.
The fixed specimens were then sliced serially at 1 cm
intervals in a sagittal plane. Three to six intrapulmonary
cartilaginous airways, which were cut in cross-section,
were randomly selected from each specimen for morpho-
metric analysis. Tissue blocks containing cartilaginous
airways in cross-section were decalcified, embedded in
paraffin, transversely cut at 5 µm thickness and stained
with haematoxylin and eosin, and with Masson's trichrome.
Additionally, five lung tissue blocks were obtained in a
stratified random fashion from a parasagittal slice for
morphological grading of membranous and respiratory
bronchioles and processed in the same way.
Measurement of airway dimensions
Sections from cartilaginous airways that did not show
bifurcation or disruption of the wall were selected for mea-
surement. Airway dimensions were measured on the hae-
matoxylin and eosin stained sections using a microscope
(Nikon) fitted with a camera lucida that superimposed
the cursor-light of a digitizing board on the microscopic
image of the airway (Bioquant; R&M Biometrics Inc.,
Nashville, TN, USA).
Airways that were too large to be viewed entirely using
a microscope were projected with a slide projector, their
images were traced onto paper, and the tracings were
measured on the digitizing board. The measurements that
were made are shown in figure 2, and include: basement
membrane perimeter (Pbm); and the area of the lumen
(and epithelium) contained within the light microscopic
image of the basement membrane(Abm); the outer mus-
cle perimeter (Pom), traced at the outer edge of the smooth
muscle layer and the enclosed area (Aom); the outer peri-
meter (Po), and the outer area (Ao) defined by the outer
DETERMINANTS OF EXPIRATORY FLOW IN COPD 1787
V 
'm
ax
  L
·s
-1
Predicted
V  L
V 
  L
P  cmH2O
V 
'm
ax
  L
·s
-1
V  L
V 
  L
P  cmH2O
Observed
75% VC
50% VC
25% VC
75% VC
50% VC
25% VC
70% VC
30% VC
70% VC
30% VC
P tm'
predicted
– + P  cmH2O
V 
'm
ax
  L
·s
-1
P tm'
observed
– + P  cmH2O
V 
'm
ax
  L
·s
-1●
●
●
Gus
predicted Gus observed
Gus%  = ∞ 100%Gus observed
Gus predicted
Fig. 1.  –  For each patient a maximal flow-static recoil (MFSR) plot is obtained by plotting maximal flow (V 'max) of the volume-flow curve
against the static transpulmonary pressures at the same lung volumes. The slope of the linear part of the MFSR plot between 70 and 30% of vital
capacity (VC) is an estimation of upstream airway conductance (Gus), and the pressure-axis intercept is an estimate of the airway collapsibility of
the flow-limiting segments (Ptm'). For each patient, a predicted MFSR curve is obtained by plotting predicted V 'max at 75, 50 and 25% of VC of
the volume-flow curve against the predicted static transpulmonary pressures at the same lung volumes. The slope of the MFSR plot between 75
and 25% vital capacity is Gus(pred), and the pressure-axis intercept is Ptm'(pred). Gus% calculated in the figure and ∆Ptm' (=Ptm'(pred)-Ptm') are
used for statistical analysis.
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Fig. 2.  –  Diagram of measured airway dimensions.
×10 %
edge of the adventitial tissue. From these measurements,
total wall area (WAtot=Ao-Abm) and inner wall area
(WAi=Aom-Abm) were calculated. The total area of car-
tilage in the airway wall (WAcart) was calculated by trac-
ing every piece of cartilage separately and calculating
the sum of the areas. 
To measure the area occupied by smooth muscle (WAm),
an automated image analysis system (Bioview, Infrascan,
Vancouver BC, Canada) was used. The smooth muscle
was segmented from the airway wall in a trichrome stained
section using operator defined colour threshholding. The
area of the muscle was calculated automatically. The
nomenclature used is according to the special commu-
nication concerning subdivisions of the bronchial wall
[16]. All measurements of airway dimensions were per-
formed by the same observer (HT). Perimeters (Pbm, Pom,
Po), were measured twice; if the difference between both
measurements exceeded 10%, they were repeated. Intra-
observer variability was assessed by remeasurement of
10 randomly selected airways with an interval of 2 months.
Interobserver variability was assessed by remeasurement
of 10 randomly selected airways by a second observer.
Measurement of bronchiolar inflammatory changes
For each specimen, 5–10 membranous airways were
graded for the severity of small airways disease using a
modification of the pictorial grading method of COSIO
and co-workers [17, 18]. The following indices were
graded: inflammation; fibrosis; muscle hypertrophy; pig-
ment deposition; goblet cell metaplasia; and squamous
cell metaplasia. For each airway, these six morphologi-
cal indices were compared with pictorial reference stan-
dards with a score from 0 (normal) to 3 (most abnormal).
Next, the mean score for each morphological index for
each individual was calculated by summing the scores
of the airways examined and dividing by the number of
airways examined. The average score for that variable
was expressed as a percentage of maximal possible
score. A total membranous airways disease score for
each specimen was then calculated by summing the mean
scores of the six morphological indices (maximal score
6×100= 600).
Statistical analysis
Correlation coefficients given are Pearson's. The rela-
tionships between airflow obstruction (FEV1, FEV1/FVC),
on the one hand, and various measures of lung recoil
(PL,max, PL,60, log k), upstream conductance (Gus%, sGus),
airway collapsibility (Ptm', ∆Ptm'), and airway dimen-
sions (WAi, WAtot, WAcart) on the other, were investi-
gated using multiple linear regression analysis.
The intra- and interobserver variability of morpho-
metric measurements were calculated by expressing the
difference between the first and second measurement as
a percentage of the average of both measurements. This
percentage difference was plotted against the average
Pbm to detect if there were systematic differences depen-
dent on airway size.
Repeated measurement analysis of variance (RM-
ANOVA), which allows for differences between and with-
in patients, was used to assess the relationships between
airway wall dimensions (WAtot, WAcart, WAm) and air-
way size (Pbm). To obtain linear regressions with approx-
imately normal distributions, it was necessary to apply
a square root transformation to the airway wall dimen-
sions. In the analysis, the airway size values were cen-
tred by subtracting the mean value for Pbm of 14 mm
from all values of Pbm. The intercept of an individual
regression line of a particular airway wall dimension as
a function of Pbm, therefore, denotes its level at a Pbm
of 14 mm. The intercept and slope of the regression
lines were investigated for their linear relationship with
FEV1 (% pred), FEV1/FVC (% pred), ∆Ptm', and Gus%
using an iterative search for optimal values. RMANO-
VA analyses the patients as a continuum and, thus,  avoids
the bias that results from dividing patients into sub-
groups [19, 20]. The level of significance was set at a
p-value equal to 0.05 (two-sided). Data are expressed as
mean±SD and range, unless otherwise indicated.
Results
Lung function
The mean lung function values of the patients in this
study are shown in table 2. Forty nine patients had no
significant airflow obstruction (FEV1/FVC >±2 SD FEV1/
FVC(pred)) 12 patients had mild airflow obstruction
(FEV1/FVC between -2 and -3 SD FEV1/FVC(pred)), and
11 patients had severe airflow obstruction (FEV1/FVC
<-3 SD FEV1/FVC(pred)). Increased functional residual
capacity (FRC >FRC(pred)+2 SD) was present in 21 out
of 72 patients, and increased residual volume (RV>RV
(pred)+2 SD) in 29 out of 72 patients. Loss of elastic
recoil pressure (k >k(pred)+ 2 SD) was present in 8 out
of 72 patients.
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Table 2.  –  Lung function characteristics
TLC  % pred n=72 109±15 (81–154)
FRC  % pred n=72 123±24 (70–177)
RV  % pred n=72 133±34 (66–219)
FEV1 % pred n=72 94±18 (58–135)
FVC  % pred n=72 96±13 (64–134)
FEV1/FVC  % pred n=72 92±12 (55–114)
PL,max % pred n=72 83±28 (28–171)
PL,90 % pred n=72 79±21 (40–141)
PL,60 % pred n=72 55±46 (10–231)
k  % pred n=72 110±51 (17–437)
B/A  % pred n=72 81±20 (40–157)
Gus% male  % pred n=44 108±49 (36–246)
Gus% female  % pred n=15 143±73 (67–283)
∆Ptm' male cmH2O n=44 0.15±1.9 (-3.8–4.8)
∆Ptm' female  cmH2O n=15 0.02±1.9 (-2.5–5.3)
Values are presented as mean±SD, and range in parenthesis.
TLC: total lung capacity; % pred: percentage of predicted value;
FRC: functional residual capacity; RV: residual volume; FEV1:
forced expiratory volume in one second; FVC: forced vital
capacity; FEV1/FVC: forced expiratory volume in one second
as fraction of forced vital capacity; PL,max: transpulmonary
pressure at TLC: PL,90: transpulmonary pressure at 90% TLC:
PL,60: transpulmonary pressure at 60% TLC: k: exponential
constant describing shape of the pressure-volume curve; B/A:
ratio describing position of the pressure-volume curve in res-
pect to the pressure axis; A: the lung volume at infinite trans-
pleural pressure; B: the lung volume difference between A and
the lung volume at a transpleural pressure of 0 cmH2O; Gus%:
airway conductance upstream of the flow-limiting segment;
∆Ptm': critical transmural pressure at which the flow-limiting
segments restrict flow calculated as Ptm'(pred) - Ptm'.
Maximal flow-static recoil curves
The MFSR curves derived from the patients contained
62±21 (SD) (range 17–125) data points in the 70–30%
VC volume interval and were linear within that interval
in 59 patients (R2=0.99±0.01; range 0.95–0.99). For 13
patients, the relationship within the 70–30% VC volume
interval was clearly not linear at the upper end. The
flow-volume curves of these patients showed that the
peak expiratory flow was not reached within the first
30% of the expired VC due to submaximal effort. A
submaximal flow-volume manoeuvre is likely to influ-
ence both the slope and the intercept of the linear part
of the MFSR curve, and these subjects were, therefore,
excluded from further analysis.
Figure 3 shows the values for Gus(pred) and Ptm'(pred)
as a function of age for male and female subjects of the
various heights. The relationship between the three pre-
dicted flow and pressure points at 75, 50 and 25% VC
was adequately described as a linear relationship for all
patients (R2=0.99; range 0.96–0.99). Multiple regression
analysis showed that Gus(pred) and Ptm'(pred) were sig-
nificantly related to age and sex. Gus(pred) increased in
males and females of 170 cm height for an increase in
age of 10 yrs by 0.04 and 0.03 L·s-1·cmH2O-1, respec-
tively (p<0.001). Gus(pred) was on average 0.15 L·s-1·
cmH2O-1 higher in males than in females (p<0.001).
Ptm'(pred) increased in males and females of 170 cm
height for an increase in age of 10 yrs by 0.25 and 0.6
cmH2O, respectively. Ptm'(pred) was higher in males
than in females (p<0.001). This difference decreased
with increasing age. Figure 4 shows the age dependence of
the predicted MFSR curve both for male and female sub-
jects.
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Morphological studies
Morphometric measurements were made on 341 car-
tilaginous airways from 72 patients (mean 4.7, range 3–
7 airways per patient). Mean airway size expressed as
the Pbm was 13.8±4.7 (5–33) mm. This corresponds to
a mean airway diameter of 4.4±1.5 (1.5–10.9) mm, or
the fifth branch ±1 [21]. The mean intraobserver vari-
ability was -8.3±7.5% for WAtot and 0.1±3.4% for WAcart.
The mean interobserver variability was -13.9±11.1% for
WAtot and 2.6±3.7% for WAcart. The intra- and inter-
observer variability for Pbm, Pom, Po, and WAm has been
described previously [22]. There was no systematic rela-
tionship between airway size (Pbm) and the intra- or inter-
observer difference for any variable. Highly significant
(p<0.001) linear relationships were found between air-
way size (Pbm) and airway wall dimensions (√WAtot,
√WAcart) (fig. 5). The linear relationships for Pbm and
WAi and WAm have been described previously [22].
The mean membranous airways disease score (MADS)
was 134±47 (14–297). Among the six parameters evalu-
ated, fibrosis followed by inflammation scored highest.
Structure function relationships
Table 3 shows pairwise the correlation coefficients for
measurements of airflow obstruction (FEV1 (% pred)
and FEV1/FVC (% pred)) and measurements of elastic
recoil (PL,max (% pred) and PL,60 (% pred)), upstream
conductance (Gus%), airway collapsibility (∆Ptm'), air-
way wall dimensions (WAi, WAcart), and airway inflam-
mation. Airflow obstruction increased with lower PL,max
(% pred), PL,60 (% pred), and Gus%. In a previous study,
we showed that airflow obstruction increased signifi-
cantly with thickening of WAi but not with WAm [22].
In this study, we found no significant correlation of air-
flow obstruction and WAtot (data not shown) or WAcart.
The predictive values of PL,max (% pred), PL,60 (% pred),
WAi, and WAcart for airflow obstruction were tested
using multiple regression analysis. It was found that
PL,60 (% pred) (p=0.006) and WAi (p=0.01) were both
most predictive regarding FEV1 (% pred) (R2=0.22)
and FEV1/FVC (% pred) (R2=0.24). PL,max (% pred) and
WAcart did not add significantly to the predictive value
for either FEV1 (% pred) or FEV1/FVC (% pred).
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Table 3.  –  Correlation coefficients of structure-function relationships
FEV1 FEV1/FVC Gus% ∆Ptm' PL,max PL,60 WAi WAcart
FEV1 % pred - 0.67*** 0.58*** NS 0.30* 0.35** -0.33** NS
FEV1/FVC  % pred 0.67*** - 0.47*** NS 0.55*** 0.40** -0.32* NS
Gus% 0.58*** 0.47*** - NS NS NS -0.25‡ NS
∆Ptm' NS NS NS - NS -0.31* NS NS
PL,max % pred 0.30* 0.55*** NS NS - 0.30* NS NS
PL,60 % pred 0.35** 0.40** NS -0.31* 0.30* - NS NS
WAi -0.33** -0.32* -0.25‡ NS NS NS - 0.31*
WAcart NS NS NS NS NS NS 0.31* -
MADS -0.30* -0.28* 0.24** NS -0.30* NS 0.4** NS
WAi: inner wall area; WAcart: area of cartilage; MADS: membranous airways disease score; NS: not significant. For further def-
initions see legend to table 2. ‡: p=0.06; *: p<0.05; **: p<0.01; ***: p<0.001.
Gus% decreased as the inner wall area became thicker
(r=-0.25; p=0.03, one-sided) or as the MADS increased
(r=-0.24; p=0.04, one-sided). Gus% did not correlate with
any of the other airway dimensions (WAtot, WAm,
WAcart). In addition, the predictive value of WAi,  WAtot,
WAm, WAcart for Gus were tested using multiple re-
gression analysis. WAi was most predictive regarding
Gus% (p=0.04), WAtot, WAm and WAcart did not add
significantly to the predictive value regarding Gus%.
∆Ptm' as an estimate of airway collapsibility did not sig-
nificantly correlate with airflow obstruction (FEV1 (%
pred), FEV1/FVC (% pred)), airway dimensions (WAtot,
WAi, WAcart, WAm), or to the MADS.
Discussion
In this study, we investigated whether airflow obstruc-
tion was related to lung elastic recoil pressure, airway
conductance and collapsibility, and whether airway
conductance and collapsibility were related to airway in-
flammation and airway wall dimensions. Airway con-
ductance and collapsibility were calculated from MFSR
plots. The results show a significant relationship bet-
ween airflow obstruction and recoil, airflow obstruction
and upstream resistance and between the inner wall area
and upstream conductance. No significant correlation
was found for the MFSR plot estimate of airway collap-
sibility and airflow obstruction or airway wall dimen-
sions or inflammation. The amount of cartilage was not
correlated to airway inflammation or to airflow obstruc-
tion.
Airflow obstruction in relation to lung elastic recoil, air-
way conductance, and airway collapsibility
One third of the patients studied suffered from mild-
to-severe airflow obstruction. Lung elastic recoil, airway
conductance, and airway collapsibility are all important
in the pathogenesis of airflow obstruction. Loss of lung
elastic recoil pressure results in a reduction of the dri-
ving force to generate airflow, and is thought to decrease
airway conductance secondary to a loss of the tethering
forces that distend the airways [1, 2, 23]. Airflow obstruc-
tion correlated significantly with loss of lung elastic re-
coil pressure in the group of patients studied.
The peripheral airway conductance has been found to
be decreased in COPD. This implies that frictional los-
ses in these airways will be increased [24, 25]. During
forced expiration, equal pressure points are formed where
lateral pressure losses due to frictional and convective
acceleration equal the lung elastic recoil pressure.  Flow-
limiting segments are formed downstream from these
equal pressure points [25]. As a result of increased fric-
tional losses and/or the loss of recoil pressure, the equal
pressure point will move upstream, to peripheral airways
that are more collapsible than central airways. Therefore,
a smaller pressure difference over the airway wall is
required to collapse the airway. In the group of patients
studied, a strong correlation was found between the air-
way conductance upstream of the flow-limiting segment
(Gus%) and airflow obstruction (FEV1, FEV1/FVC).
Airway collapsibility of the flow-limiting segment is
thought to be an important determinant of airflow ob-
struction. In the present study, no significant correlation
was found between the collapsibility of the flow-limit-
ing segment as derived from the MFSR plot (∆Ptm') and
airflow obstruction. This could mean that collapsibility
might not be an important factor, or that the ∆Ptm' does
not adequately represent the collapsibility of the flow-
limiting segment. We think the latter is true for reasons
stated below.
Airway conductance and collapsibility versus structure
and inflammatory changes
Reduced airway conductance can result from inflam-
matory thickening of the airway wall, contraction of air-
way smooth muscle, loss of tethering forces by the
parenchyma which surrounds the airways, and the pres-
ence of secretions within the lumen. COSIO et al. [17]
showed that inflammation of the airways was related to
airflow obstruction; although this was not confirmed in
a more recent study in a large group of patients [2].
Inflammation has been found to be related to the thick-
ness of the airway wall both in cartilaginous and non-
cartilaginous airways of patients with COPD [22, 26,
27]. In addition, we and others have previously shown
that the thickness of the inner wall area is related to air-
flow obstruction (FEV1/FVC%) [22, 26]. In the present
study, a significant correlation was found between the
thickness of the inner airway wall area and Gus%. No
significant relationship was found between Gus% and
total airway wall thickness, which is likely to be explained
by the more variable measurement of the latter.
During forced expiration, the airways will be com-
pressed at and downstream from the flow-limiting seg-
ments and, therefore, maximal airflow is limited [25].
Airway wall structure and diameter are important deter-
minants of the compressibility of the airway at the site
of the flow-limiting segments. It is thought that the Ptm'
as calculated from the MFSR model reflects the com-
pressibility of the airways at the flow-limiting segment.
The present study provides a number of observations that
argue against the validity of Ptm' as a measure of the
collapsibility of the flow-limiting segments. Firstly, air-
way cartilage is considered to be an important structure
that resists dynamic compression [28]. We therefore ex-
pected a significant correlation between the amount of
cartilage and Ptm'. In the present study, no such correla-
tion could be demonstrated. Since the mechanical prop-
erties of airway cartilage were not investigated, it cannot
exclude that these properties would relate to airway
collapsibility. In fact, MORENO et al. [29] showed that
the proteolytic enzyme, papain, could weaken airway
cartilage, while its histological appearance remained un-
changed. 
Secondly, it is likely that chronic inflammation affects
the collapsibility of the airways at the flow-limiting seg-
ment. However, in the present study, no such significant
correlation could be detected between airway inflamma-
tion parameters and ∆Ptm'. Thirdly, increased thickness
of the airway wall would be expected to decrease air-
way collapsibility [30]. Again, no correlation was found
between total airway wall thickness, or inner wall thick-
ness and ∆Ptm'.
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Fourthly, airflow obstruction itself did not correlate to
∆Ptm'. Finally, we did not find an increase of Ptm' with
age, as was predicted by our reference values. The in-
crease in Ptm'(pred) is in agreement with the study by
YERNAULT et al. [31], who found an increase of Ptm' ver-
sus age in a group of 74 healthy subjects. But, as was
stated by these authors, a number of studies showed that
airway compliance decreases with age [32, 33]. The
increase of Ptm' with age could be explained by a more
peripheral position of the flow-limiting segment, since
peripheral airways are known to be more compliant than
central airways [34]. 
We did not study whether smooth muscle tone or  par-
enchymal tethering forces were correlated to ∆Ptm'.
Constriction of smooth muscle is known to decrease air-
way collapsibility [28, 35]. The importance of the lung
parenchyma for airway collapsibility is still a matter of
debate. The alveolar walls attach to the outside of the
airway and probably provide an elastic load to airway
smooth muscle when it shortens or when the airway is
compressed [36]. LAMB et al. [37] found that loss of these
alveolar attachments was associated with airflow ob-
struction; this was not found by others [2]. Since we
found no significant correlations between airway dimen-
sions, inflammation, or airflow obstruction and ∆Ptm',
we think it unlikely that Ptm' is a valid estimate of the
collapsibility of the flow-limiting segment. Calcula-
tion of Ptm' is determined by extrapolation of the MFSR
curve to zero flow. This extrapolation assumes a linear
behaviour of the maximal flow versus static recoil rela-
tionship below 30% FVC. If the pressure-flow relation-
ship deviates from a linear relationship below 30% FVC,
the actual and predicted zero flow intercept could be very
different.
Airway cartilage, inflammation and airflow obstruction
Previous studies have suggested that chronic inflam-
mation reduces cartilage volume and, therefore, contribu-
tes to increased airflow obstruction [3, 6, 38, 39]. This
was not confirmed in other studies [7, 8]. In the present
study, we could not demonstrate a correlation between
inflammatory changes in the airways and the amount of
airway cartilage, nor a correlation between the amount
of cartilage and the severity of airflow obstruction. The
older studies that investigated the relationship between
inflammation and airway cartilage were handicapped by
the fact that the appropriate method to correct for air-
way size was not yet known [40]. A recent study by NAGAI
et al. [6] expressed cartilage as a volume proportion of
the total wall area. Inflammation of the airways results
in an increased thickness of the airway wall and, there-
fore, could result in a reduced volume proportion of air-
way cartilage [22]. Since we investigated a large number
of patients and corrected for airway size, we think that
the volume of cartilage is not reduced by inflammation
and is not related to airflow obstruction.
Predicted values of airway conductance and airway col-
lapsibility
To our knowledge, no reference values are available for
Gus and Ptm'. In previous studies, Gus was corrected for
lung volume by dividing Gus by the predicted or actual
TLC of the subject (table 4) [9, 41]. In these studies,
patients were compared to a limited number of healthy
subjects, without matching for age or sex. YERNAULT et
al. [31] described an increase in Gus with age that was
comparable for males and females. Gus was higher in
males than in females. We calculated predicted values
for Gus and Ptm' (Gus(pred) and Ptm'(pred)) for each
patient using reference values both for elastic recoil pres-
sure and maximal expiratory flows [11, 14]. In agree-
ment with the study of YERNAULT et al. [31], Gus(pred)
and Ptm'(pred) increased with age and were higher for
males than for females. An increase in Gus with age has
been described by a number of authors [31, 42–44]. The
decrease of maximal flows at fixed lung volumes, with in-
creasing age, is predominantly related to decreased lung
elastic recoil pressure. Our results suggest that the decre-
ase in recoil is greater than the decrease in flow. We spe-
culate that this preservation of flow could be the result
of a disproportionately greater loss of elasticity in the
airways relative to the loss of recoil in the parenchyma.
This could cause airways to be more distended at any
lung elastic recoil pressure.
Our predicted values for Gus and Ptm' were derived from
two prediction equations generated in different groups
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Table 4.  –  Maximal flow-static recoil estimates of airway conductance and collapsibility
First        [Ref]  Ptm' sGus
author                                                  n                    cmH2O                             cmH2O·s-1
LEAVER [9] Controls 10 -0.8 (-3.8–1.7) 0.09 (0.06–0.12)
ZAMEL [41] Controls 6 - (0.5–0.9) - (0.08–0.14)
Tiddens Predicted, all 59 1.05 (-0.95–2.5) 0.11 (0.08–0.15)
Predicted, male 44 1.24 (0.13–2.54) 0.12 (0.10–0.15)
Predicted, female 15 0.51 (-0.95–1.97) - (0.08–0.14)
LEAVER [9] Patients 17 3.1 (0.6–5.8) 0.05 (0.02–0.08)
ZAMEL [41] Emphysema 5 - (1.1–2.7) - (0.08–0.19)
ZAMEL [41] Peripheral obstr. 2 - (1.5–3.3) - (0.05–0.09)
Tiddens Patients, all 59 0.12 (-3.8–5.3) 0.13 (0.03–0.29)
Male 44 0.15 (-3.8–4.8) 0.12 (0.03–0.29)
Female 15 0.02 (-2.5–5.3) 0.14 (0.07–0.26)
sGus: specific conductance upstream of the flow-limiting segment calculated as Gus divided by TLC of patient;
Ptm': collapsibility of flow-limiting segment; Peripheral obstr.: patients with obstruction of peripheral airways.
of normal subjects. It can be argued that the increase in
predicted Gus is an artifact caused by combining the two
sources of data. However, we do not believe that this is the
case. The mean value for Gus, for the nine normal male
subjects of LEAVER et al. [9] (mean Gus=0.65 L·s-1·cmH2O-1;
mean age=35 yrs) fall within the predicted normal range
(fig. 3). In addition, in this study we calculated the mean
Gus for the 23 male subjects (mean age 63 yrs; height
174 cm) without airflow obstruction (FEV1/VC (pred)
>-2 SD) and for the 21 male subjects (mean age 62 yrs;
height 173 cm) with airflow obstruction (FEV1/VC(pred)
<-2 SD). For patients without airflow obstruction, Gus was
1.04 L·s-1·cmH2O-1 (134% pred), for patients with air-
flow obstruction Gus was 0.63 L·s-1·cmH2O-1 (80% pred).
The increased Gus in the patients without airflow ob-
struction could be explained by the same process that we
have invoked from the age-related increases; a greater
loss of airway elasticity than lung elasticity. The decrea-
sed Gus in the patients with airflow obstruction is likely
to be caused by inflammatory thickening of the inner
wall area.
In conclusion, in a group of 59 chronic obstructive pul-
monary disease patients, strong correlations were found
between airflow obstruction on the one hand and lung
elastic recoil and airway conductance on the other. No
correlation was found between airflow obstruction and
measures of airway collapsibility. Airway conductance
was correlated to the inner wall thickness. No correla-
tion was found between airflow obstruction and the vol-
ume of airway cartilage. Nor was there a significant
correlation between the volume of the cartilage and air-
way inflammation. Therefore, changes in the amount
of cartilage are probably not important for the patho-
genesis of chronic obstructive lung disease. Finally,
none of the airway dimensions was related to the maxi-
mal flow-static recoil plot estimate of airway collapsi-
bility. Therefore, we think that the maximal flow static
recoil model does not adequately estimate the collapsi-
bility of the flow-limiting segment.
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